Hindalco extends CFIUS review timeline to July 2
Hindalco Industries announced an extension of the CFIUS review timeline for the AluChem acquisition to July 2, 2026, due to a partial US government shutdown. The company filed necessary documentation for the extension and confirmed other details remain unchanged.

*this image is generated using AI for illustrative purposes only.
hindalco industries has provided a fourth update regarding the proposed acquisition of AluChem Companies, Inc. by its step-down wholly owned subsidiary, Aditya Holdings LLC. The company informed the exchanges that the statutory timelines under the CFIUS review framework were impacted due to a partial shutdown of the U.S. federal government.
Consequently, the review process has been extended, with the new completion timeline set for July 2, 2026. The company stated that necessary documentation has been filed to facilitate this additional extension.
Regulatory Background
The intimation was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hindalco Industries had previously filed both 'short-form' and 'long-form' declarations with CFIUS in connection with the proposed transaction.
Key Timeline Details
| Event | Date |
|---|---|
| Previous Intimations | June 24, 2025; October 23, 2025; February 11, 2026; February 26, 2026 |
| Revised CFIUS Review Completion | July 2, 2026 |
The company confirmed that all other details regarding the transaction remain unchanged as per previous intimations. Further updates will be provided as material developments occur or upon the completion of the review process.
Historical Stock Returns for Hindalco Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.27% | +2.44% | +8.28% | +37.45% | +65.87% | +185.38% |
If CFIUS raises national security concerns during its extended review, what alternative deal structures or asset divestitures could Hindalco consider to salvage the AluChem acquisition?
How might the prolonged regulatory uncertainty around the AluChem deal impact Hindalco's broader capital allocation strategy and other potential M&A opportunities in the near term?
What are the financial penalties or deal-termination risks for Hindalco if the CFIUS review extends beyond the July 2, 2026 deadline or results in a blocked transaction?


































